Quarterly report pursuant to Section 13 or 15(d)

Goodwill and In-process R&D (Details)

v3.21.1
Goodwill and In-process R&D (Details) - USD ($)
3 Months Ended 12 Months Ended 15 Months Ended
Mar. 31, 2021
Dec. 31, 2018
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2017
Goodwill and In-Process R&D          
Goodwill $ 1,452,338   $ 1,452,338 $ 1,452,338  
Goodwill impairment loss $ 0   $ 0    
Pelican Therapeutics, Inc.          
Goodwill and In-Process R&D          
Indefinite-lived Intangible Assets Acquired   $ 5,900,000      
Goodwill         $ 2,200,000